[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
About the Journal
Editorial Board
Keywords
For Authors::
Aims and Scope
Call for Papers
Submission Instructions
For Reviewers::
Referee page
Subscription::
Subscription Form
News & Events::
Journal News
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE
Volume 17, Issue 3 (6-2019)                   Int J Radiat Res 2019, 17(3): 505-508 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jiang Y, Zhu X. Safe chemotherapy and targeted therapy for  treating locally advanced NPC in a G6PD-deficient patient: case report and literature review . Int J Radiat Res 2019; 17 (3) :505-508
URL: http://ijrr.com/article-1-2613-en.html
Safe chemotherapy and targeted therapy for  treating locally advanced NPC in a G6PD-deficient patient: case report and literature review
Y.M Jiang , X.D. Zhu
Department of Radiation Oncology, Cancer Hospital of Guangxi Medical University, Nanning530021, People's Republic of China , zhuxiaodonggxmu@163.com
Abstract:   (3645 Views)
The article was first report a case of a 32-year-old female with NPC that is G6PD-deficient. The patient completed induction chemotherapy and concomitant chemoradiotherapy successfully. The patient experienced grade 1 neutropenia , grade 1 diarrhea, and grade 2 acne-like skin reactions during the three cycles of  induction chemotherapy. Grade 1 neutropenia, grade 1 diarrhea, grade 2 oral mucositis  and grade 1  skin reactions were observed during the concomitant chemoradiotherapy. No hemolytic events were observed. We conclude that it is safe for G6PD-deficient patients with NPC to received chemotherapy and targeted therapy.
Keywords: nasopharyngeal carcinoma, G6PD deficiency, chemotherapy, cetuximab, radiotherapy.
Full-Text [PDF 1599 kb]   (2806 Downloads)    
Type of Study: Case Report | Subject: Radiation Biology
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
International Journal of Radiation Research
Persian site map - English site map - Created in 0.06 seconds with 48 queries by YEKTAWEB 4718